These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28245613)

  • 1. From Lysosomal Storage Diseases to NKT Cell Activation and Back.
    Pereira CS; Ribeiro H; Macedo MF
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
    Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients.
    Pereira CS; Pérez-Cabezas B; Ribeiro H; Maia ML; Cardoso MT; Dias AF; Azevedo O; Ferreira MF; Garcia P; Rodrigues E; Castro-Chaves P; Martins E; Aguiar P; Pineda M; Amraoui Y; Fecarotta S; Leão-Teles E; Deng S; Savage PB; Macedo MF
    Front Immunol; 2019; 10():1264. PubMed ID: 31214199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chewing the fat on natural killer T cell development.
    Godfrey DI; McConville MJ; Pellicci DG
    J Exp Med; 2006 Oct; 203(10):2229-32. PubMed ID: 17000869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected].
    Muindi K; Cernadas M; Watts GF; Royle L; Neville DC; Dwek RA; Besra GS; Rudd PM; Butters TD; Brenner MB
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3052-7. PubMed ID: 20133624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development.
    Sandrock I; Ziętara N; Łyszkiewicz M; Oberdörfer L; Witzlau K; Krueger A; Prinz I
    PLoS One; 2015; 10(12):e0145010. PubMed ID: 26673421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases.
    Torina A; Guggino G; La Manna MP; Sireci G
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
    Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
    Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs.
    Wang C; Liu X; Li Z; Chai Y; Jiang Y; Wang Q; Ji Y; Zhu Z; Wan Y; Yuan Z; Chang Z; Zhang M
    Sci Rep; 2015 Sep; 5():14124. PubMed ID: 26369936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal glycosphingolipid recognition by NKT cells.
    Zhou D; Mattner J; Cantu C; Schrantz N; Yin N; Gao Y; Sagiv Y; Hudspeth K; Wu YP; Yamashita T; Teneberg S; Wang D; Proia RL; Levery SB; Savage PB; Teyton L; Bendelac A
    Science; 2004 Dec; 306(5702):1786-9. PubMed ID: 15539565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation.
    Kronenberg M
    J Vis Exp; 2007; (10):635. PubMed ID: 18989407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKT cells in leishmaniasis.
    Zamora-Chimal J; Hernández-Ruiz J; Becker I
    Immunobiology; 2017 Apr; 222(4):641-646. PubMed ID: 28012583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune evasion of the CD1d/NKT cell axis.
    Brutkiewicz RR; Yunes-Medina L; Liu J
    Curr Opin Immunol; 2018 Jun; 52():87-92. PubMed ID: 29734045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT and tolerance.
    Diana J; Beaudoin L; Gautron AS; Lehuen A
    Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of immune abnormalities in lysosomal storage disorders.
    Rigante D; Cipolla C; Basile U; Gulli F; Savastano MC
    Immunol Lett; 2017 Aug; 188():79-85. PubMed ID: 28687233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.
    Arrenberg P; Halder R; Kumar V
    J Cell Physiol; 2009 Feb; 218(2):246-50. PubMed ID: 18814145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal storage diseases--the horizon expands.
    Boustany RM
    Nat Rev Neurol; 2013 Oct; 9(10):583-98. PubMed ID: 23938739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired autophagy: The collateral damage of lysosomal storage disorders.
    Myerowitz R; Puertollano R; Raben N
    EBioMedicine; 2021 Jan; 63():103166. PubMed ID: 33341443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism.
    Schümann J; Facciotti F; Panza L; Michieletti M; Compostella F; Collmann A; Mori L; De Libero G
    Eur J Immunol; 2007 Jun; 37(6):1431-41. PubMed ID: 17492806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.